These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5478406)

  • 1. Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Life Sci I; 1970 Sep; 9(18):1021-32. PubMed ID: 5478406
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary studies of schizophrenics and controls.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Biol Psychiatry; 1971; 3(1):9-20. PubMed ID: 4398666
    [No Abstract]   [Full Text] [Related]  

  • 3. Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
    Spaide J; Tanimukai H; Ginther R; Bueno J; Himwich HE
    Life Sci; 1967 Mar; 6(5):551-60. PubMed ID: 4226702
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

  • 5. Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Life Sci; 1967 Aug; 6(16):1697-706. PubMed ID: 6057885
    [No Abstract]   [Full Text] [Related]  

  • 6. Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
    Spaide J; Neveln L; Tolentino J; Himwich HE
    Biol Psychiatry; 1969 Jul; 1(3):227-33. PubMed ID: 5352654
    [No Abstract]   [Full Text] [Related]  

  • 7. Behavioral and biochemical alterations in schizophrenic patients.
    Spaide J; Tanimukai H; Bueno JR; Himwich HE
    Arch Gen Psychiatry; 1968 Jun; 18(6):658-65. PubMed ID: 5651509
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor.
    Berlet HH; Matsumoto K; Pscheidt GR; Spaide J; Bull C; Himwich HE
    Arch Gen Psychiatry; 1965 Dec; 13(6):521-31. PubMed ID: 5841751
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of tranylcypromine and L-cysteine on plasma amino acids in controls and schizophrenic patients.
    Davis JM; Spaide JK; Himwich HE
    Am J Clin Nutr; 1972 Mar; 25(3):302-10. PubMed ID: 5011913
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical research in schizophrenia.
    Boulton AA
    Nature; 1971 May; 231(5297):22-8. PubMed ID: 4930468
    [No Abstract]   [Full Text] [Related]  

  • 11. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlations between behavior of schizophrenic patients and the urinary excretions of indoles, catechols and steroids.
    Himwich HE
    Folia Psychiatr Neurol Jpn; 1965; 19(4):326-45. PubMed ID: 5899882
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chromatographic separation of tryptophan metabolites on thin-layer silica gel].
    Kniazev IuA; Marchenko LF; Vakhrusheva LL; Denisov BE
    Lab Delo; 1971; 2():114-7. PubMed ID: 4104384
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 15. A biochemical study of early infantile austism.
    Himwich HE; Jenkins RL; Fujimori M; Narasimhachari N; Ebersole M
    J Autism Child Schizophr; 1972; 2(2):114-26. PubMed ID: 5068665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlation between disturbances of tryptophan metabolism induced by methionine and nialamide administration and changes of the mental state in chronic schizophrenic patients].
    Jus A; Rosengarten H; Wardaszko-Lyskowska H; Szemis A; Stencka K; Wlosińska I; Krzyzowski J; Kowalska K
    Psychiatr Pol; 1970; 4(4):365-71. PubMed ID: 5472573
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma amino acids in schizophrenic patients with methionine or cysteine loading and a monoamine oxidase inhibitor.
    Spaide JK; Davis JM; Himwich HE
    Am J Clin Nutr; 1971 Sep; 24(9):1053-9. PubMed ID: 5094479
    [No Abstract]   [Full Text] [Related]  

  • 18. Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring.
    Narasimhachari N; Himwich HE
    Biochem Biophys Res Commun; 1973 Dec; 55(4):1064-71. PubMed ID: 4520847
    [No Abstract]   [Full Text] [Related]  

  • 19. The determination of bufotenin in urine of schizophrenic patients and normal controls.
    Narasimhachari N; Himwich HE
    J Psychiatr Res; 1972 Jun; 9(2):113-21. PubMed ID: 5071936
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary amines in chronic schizophrenia.
    Perry TL; Hansen S; MacDougall L
    Nature; 1966 Oct; 212(5058):146-8. PubMed ID: 5339580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.